|
Match
|
Document |
Document Title |
|
|
US20090111761 |
Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions
The present invention relates to the formulation and delivery of prostaglandin analogs to treat epithelial-related condition. In some embodiments, the compositions of the invention are used to... |
|
|
US20070141162 |
Injectable compositions for the controlled delivery of pharmacologically active compound
The present invention provides compositions and methods for extending the release times and lowering the toxicity of pharmacologically active compounds. The compounds comprise a salt of the... |
|
|
US20070116649 |
Antibiotic formulations, unit doses, kits, and methods
An aqueous or powder composition includes anti-gram-negative antibiotic or salt thereof being present at an amount ranging from about 100 mg/ml to about 200 mg/ml. Another aqueous or powder... |
|
|
US20060153786 |
Compositions and methods for treating conditions of the nail unit
The biodegradable drug delivery systems described here are formulated for implantation into the nail unit and its surrounding tissues for the treatment of various nail unit conditions. The systems... |
|
|
US20060140990 |
Composition for topical treatment of mixed vaginal infections
A pharmaceutical composition comprises (a) an antibacterial agent in an antibacterially effective amount, illustratively comprising clindamycin or a pharmaceutically acceptable salt or ester... |
|
|
US20050207987 |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from... |
|
|
US20050201947 |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from... |
|
|
US20050130914 |
Methods of administering dalbavancin for treatment of skin and soft tissue infections
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in... |
|
|
US20140179625 |
SODIUM CHANNEL BLOCKERS
The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. |
|
|
US20100099641 |
CRYSTALLINE FORM OF 1-CHOLORO-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
The invention relates to a crystalline form of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran
-3-yloxy)-benzyl]-benzene, to a method for the preparation thereof, as well as to the... |
|
|
US20080167255 |
4-BIARYLYL-1-PHENYLAZETIDIN-2-ONES
4-Biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed. The compounds are of the general formula in which represents an aryl or heteroaryl residue; Ar... |
|
|
US20050130909 |
Dalbavancin compositions for treatment of bacterial infections
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of a mixture of dalbavancin multimers and monomers for... |
|
|
US20050090433 |
Dalbavancin compositions for treatment of bacterial infections
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of a mixture of dalbavancin multimers and monomers for... |
|
|
US20130137651 |
GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS
The present invention relates to a solid powder composed of a mixture of a natural or a synthetic polymer which forms a gel, a buffer, such as an hydroxyacid or a dicarboxyacid, a saccharide, one... |
|
|
US20070202055 |
Pharmaceutical Formulations
An aspect of the present invention provides for a medicament suitable for administration as a nasal inhalant including an aqueous carrier and suspended therein particulate pleconaril, the aqueous... |
|
|
US20140228287 |
1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-PIPERIDIN-1-YL]-AXANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL
A pharmaceutical composition includes 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8
-[3-(R)-amino-piperidin-1-yl]-xanthine or a pharmaceutically acceptable form thereof as... |
|
|
US20090137499 |
BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE
The present invention relates to a benzylphenyl glucopyranoside derivative having an excellent inhibitory effect on human SGLT1 and/or SGLT2 activity. There is provided a compound or a... |
|
|
US20080108580 |
NOVEL AROMATIC FLUOROGLYCOSIDE DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THE USE THEREOF
Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof. The invention relates to substituted aromatic fluoroglycoside derivatives of the formula I... |
|
|
US20060142183 |
Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
The present invention related to a new composition, use and method to improve the cure of infections caused by antibiotic resistant microbial pathogens, in particular beta-lactam resistant... |
|
|
US20050008704 |
Pharmaceutical composition for solubility enhancement of hydrophobic drugs
The present invention provides a pharmaceutical composition having enhanced solubility comprising a drug and polyethylene glycol, wherein the ratio of polyethylene glycol to drug by weight is from... |
|
|
US20130184229 |
HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS
Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating... |
|
|
US20080214481 |
Methods of Treatment of Endobronchial Infections
The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition... |
|
|
US20070218038 |
STABILIZED, STERILIZED COLLAGEN SCAFFOLDS WITH ACTIVE ADJUNCTS ATTACHED
Bioimplants and methods of making the bioimplants are provided. The bioimplants comprise biological tissues having conjugated thereto adjunct molecules. The biological tissues are sterilized with... |
|
|
US20050255048 |
Sprayable formulations for the treatment of acute inflammatory skin conditions
A topical spray or foam, methods of making the formulation, and methods of use thereof, has been developed. In one preferred embodiment, the composition includes one or more active agents and... |
|
|
US20050095205 |
Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
This invention relates to formulations for topical use comprising antibiotics in combination with anti-inflammatory steroids for treating ophthalmic infections and attendant inflammation. More... |
|
|
US20070036731 |
Topical Delivery with a Carrier Fluid
Aerosol spray formulations capable of delivering high concentrations of active agent-containing materials and/or excipient are described herein. The formulation contains a carrier fluid, a... |
|
|
US20060292199 |
PMMA bone cement containing antibiotic/antibiotics
A PMMA bone cement containing an antibiotic/antibiotics is described which is characterized in that, in the powder component, 0.1-5.0% by weight of water soluble, glasstype antibiotic/antibiotics... |
|
|
US20160129036 |
ADENOSINE ANALOGS AND THEIR USE
The invention provides adenosine analog compounds that act at P2Y receptors, e.g., the P2Y2 receptor, including pharmaceutical compositions; and uses thereof to treat or prevent diseases... |
|
|
US20130274101 |
Synergistic Fungicidal Active Substance Combinations
The novel active compound combinations of a carboxamide of the general formula (I) (group 1) in which R, G, R1 and A have the meanings given in the description and the active compound groups (2)... |
|
|
US20070269385 |
DEVICES, METHODS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AGENTS FOR THE TREATMENT OF SINUSITIS, RHINITIS, AND OTHER DISORDERS
Methods and kits for delivering pharmaceutical agents to the sinuses, sinus ostia, Eustachian tube, and pharynx are presented. A needle tip is translated through the mucosal tissue layer to a... |
|
|
US20070202050 |
Pharmaceutical Formulations
An aspect of the present invention provides for a medicament including a solution containing pleconaril or a pharmaceutically acceptable salt thereof, wherein at least one solvent comprising said... |
|
|
US20110190199 |
Combination Therapy for Tuberculosis
The present invention relates to methods of treating tuberculosis, including multi-drug resistant varieties and latent tuberculosis. More particularly, the present invention relates to a method of... |
|
|
US20100009927 |
Anti-Inflammatory and Anti-Allergy Extracts from Nettle
The present invention relates in part to nettle extracts that are useful for treating or preventing seasonal allergies, allergic rhinitis, and other inflammatory conditions. |
|
|
US20070161544 |
SELECTIVE TARGETING AGENTS FOR MITCOCHONDRIA
The present invention relates to compositions and methods for providing mitochondria-selective targeting agents covalently linked to desired cargo such as radical scavenging agents. Compositions... |
|
|
US20070141139 |
COMPOSITION FOR INTESTINAL DELIVERY
The present invention relates to a new composition, use and method for oral administration to a human or an animal of a physiologically active agent comprising neutralizing agents to increase pH... |
|
|
US20060222716 |
Colloidal solid lipid vehicle for pharmaceutical use
The invention provides a drug carrier that includes a solid lipid nanoparticle (SLN), wherein the SLN includes tocopherol or a derivative thereof. The invention also provides a pharmaceutical... |
|
|
US20050004049 |
Novel griseofulvin compositions
The present invention is directed to nanoparticulate compositions comprising griseofulvin. The griseofulvin particles of the composition preferably have an effective average particle size of less... |
|
|
US20070122490 |
Wound healing compound
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprise a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or wound... |
|
|
US20070098747 |
Topical pharmaceutical composition for the treatment of inflammatory dermatoses
Provided is a topical pharmaceutical composition for the treatment of inflammatory dermatoses, including acne vulgaris, together with methods for its use. The composition and methods involve the... |
|
|
US20070071686 |
Liquid preparation containing tobramycin
The application describes a sterile aqueous inhalation solution containing the active agent tobramycin. The preparation has a high content of active agent (about 80 to 120 mg/ml of tobramycin) and... |
|
|
US20060286146 |
Hemostatic compositons and methods
The present invention provides methods and compositions involving resorbable hemostatic agents that have the essential absence of microfibrillar collagen. Resorbable hemostatic agents of the... |
|
|
US20060045874 |
Aminoglycoside treatment for lysosomal storage diseases
The present invention provides a method of treating lysosomal storage diseases such as Hurler syndrome and Batten disease in individuals in need of such treatment, comprising the step of... |
|
|
US20140155263 |
Fungicidal Mixtures Based on Azolopyrimidinylamines
Fungicidal mixtures comprising, as active components, 1) azolopyrimidinylamines of the formula I, in which the substituents are as defined in the description and 2) at least one active compound II... |
|
|
US20050159369 |
Method of treatment of otitis externa
This invention relates to a method of treating otitis externa using a topical combination medication, including one or more antifungal agent such as, for example fluconazole, voriconazole,... |
|
|
US20160067296 |
Compositions and Methods for Joint Health
The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of modulating joint inflammation, joint pain, joint stiffness,... |
|
|
US20120202762 |
METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES
Methods are provided for using a compound to treat, for example, endothelial dysfunction including vascular abnormalities. More specifically, methods are described for using an oligosaccharide... |
|
|
US20110038853 |
Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis
The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in... |
|
|
US20160367497 |
METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES
Methods of treating or preventing axonal degradation in neuropathic diseases and neurological disorders in mammals are disclosed. The methods can comprise administering to the mammal an effective... |
|
|
US20140178303 |
HETEROBIFUNCTIONAL PAN-SELECTIN INHIBITORS
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the... |
|
|
US20080044390 |
Methods and compositions for the treatment of neurodegenerative disorders
The present invention features compositions, kits, and methods for treating, preventing, and ameliorating neurodegenerative disorders, e.g., Huntington's disease. |